| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,142 |
4,205 |
$379K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,223 |
3,712 |
$203K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,302 |
2,017 |
$176K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,493 |
2,124 |
$172K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
790 |
707 |
$59K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
325 |
295 |
$27K |
| 90677 |
|
249 |
235 |
$23K |
| 90670 |
|
1,582 |
1,396 |
$18K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
805 |
743 |
$13K |
| 90680 |
|
1,142 |
1,000 |
$12K |
| 90723 |
|
1,116 |
988 |
$12K |
| 90647 |
|
982 |
851 |
$12K |
| 90633 |
|
787 |
669 |
$9K |
| 83655 |
|
727 |
644 |
$8K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
491 |
441 |
$8K |
| 90710 |
|
443 |
369 |
$6K |
| 90686 |
|
491 |
472 |
$5K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
97 |
94 |
$4K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
249 |
241 |
$4K |
| 90698 |
|
212 |
171 |
$3K |
| 90734 |
|
148 |
104 |
$2K |
| 85018 |
|
653 |
591 |
$1K |
| 96160 |
|
154 |
135 |
$1K |
| 87807 |
|
126 |
101 |
$1K |
| 90648 |
|
190 |
172 |
$1K |
| 90651 |
|
51 |
30 |
$806.26 |
| 90661 |
|
37 |
37 |
$690.95 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
48 |
38 |
$681.50 |
| 90715 |
|
48 |
29 |
$588.16 |
| 90700 |
|
41 |
24 |
$348.64 |
| 90744 |
|
30 |
27 |
$261.75 |
| 90696 |
|
13 |
13 |
$218.07 |
| 90656 |
|
12 |
12 |
$201.36 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
13 |
12 |
$1.42 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
315 |
297 |
$0.00 |
| 90461 |
|
35 |
33 |
$0.00 |